検索結果

Company Profile | About Senju | SENJU Pharmaceutical

512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi...

千寿製薬株式会社

or Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） News List OTC Products, etc.

, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into a LicensingAgreement for Corneal Esthesiometer Brill in Japan with Brill International (Headquart...

千寿製薬について | 千寿製薬株式会社

CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy

OTC Products, etc. | Products | SENJU Pharmaceutical

almia by ultraviolet rays etc. (snow blindness etc.) Prevention of eye troubles (after swimming, or to wash out sweat or dust etc.) Blepharitis (running eye) Eye-lotions for contact lenses Refine sear...